Abstract
Despite major recent therapeutic improvements, septic shock remains a leading cause of mortality in intensive care patients [1]. In addition, it is important to realize that the mortality rate of patients with septic acute kidney injury (AKI) is much higher than that of patients with non-septic AKI [2]. For more than a decade, it has been suggested that reducing blood cytokine levels in such patients could, at least theoretically, lead to reduced mortality [3, 4]; however, in view of the complexity of the pharmacodynamics and pharmacokinetics of cytokines, this concept is not so simple to apply. Indeed, recent studies have attempted to demonstrate that high volume hemofiltration (HVHF) with enhanced adsorption can modulate and ameliorate sepsis-induced hemodynamic instability [5]. This recently published paper [5] suggested that membranes with enhanced adsorption are the key and that increased extraction from the central circulation is sufficient to obtain a beneficial clinical effect. It seems at least theoretically reasonable that effectively removing mediators from the tissue where they are harmful, and transporting them to the central circulation must be effective. Therefore, HVHF and enhanced adsorption should work synergistically in this model. In order to consolidate this hypothesis, it seems fruitful to discuss the three separate theories that have been put forward in recent years as possible explanations for the clinical findings observed in septic patients who underwent a number of different blood purification techniques. The HVHF and hybrid techniques that are currently available to the clinician are diverse and deserve a brief description.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Vincent JL, Atalan HK (2008) Epidemiology of severe sepsis in the intensive care unit. Br J Hosp Med 69: 442–443
Parmar A, Langenberg C, Wan L, May CN, Bellomo R, Bagshaw SM (2010) Epidemiology of septic acute kidney injury. Curr Drug Targets (in press)
Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern 119: 771–778
Damas P, Canivet JL, de Groote D, et al (1997) Sepsis and serum cytokine concentrations. Crit Care Med 25: 405–412
Rimmele T, Assadi A, Cattenoz M, et al (2009) High-volume haemofiltration with a new haemofiltration membrane getting enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 24: 421–427
Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351: 159–169
Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R (2008) Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36: 198–203
Hotchkiss RS, Swanson PE, Freeman BD, et al (1999) Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med 27: 1230–1251
Bellomo R, Wan L, Langenberg C, May C (2008) Septic acute kidney injury: new concepts. Nephron Exp Nephrol 4: 95–100
Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35: 2408–2416
Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bellomo R (2003) Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 27: 792–801
Ronco C, Bellomo R (2002) Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 25: 733–747
Ronco C, Ricci Z, Bellomo R (2002), Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTRA ERCA J 2: 13–18
Honoré PM, Joannes-Boyau O (2004) High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 27: 1077–1082
Honore PM, Matson JR (2004) Extracorporeal removal for sepsis: acting at the tissue level — the beginning of a new era for this treatment modality in septic shock. Crit Care Med 32: 896–897
Honoré PM, Jamez J, Wauthier M, Dugernier T (1998) Prospective evaluation of short-time high volume isovolemic hemofiltration on the haemodynamic course and outcome of patients with refractory septic shock. Crit Care Nephrol 90: 87–99
Honoré PM, Zydney AL, Matson JR (2003) High volume and high permeability haemofiltration in sepsis. The evidences and the key issues. Care Crit III 3: 69–76
Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ (2002) Continuous venovenous hemofiltration improves hemodynamic in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 15: 150–157
Di Carlo JV, Alexander SR (2005) Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Int J Artif Organs 28: 777–786
Olszewski WL (2003) The lymphatic system in body homeostasis: physiological conditions. Lymph Fat Res BioI 1: 11–21
Onarherim H, Missavage E, Gunther RA, Kramer GC, Reed RK, Laurent TC (1991) Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res 50: 259–265
Wasserman K, Mayerson HS (1952) Dynamics of lymph and plasma protein and exchange. Cardiologia 21: 296–307
Honore PM, joannes-Boyau O, Collin V, Boer W, Gressens B, Janvier G (2008) Practical daily management of extra-renal continuous removal. Reanimation 17: 472–478
Honoré PM, Matson JR (2002) Hemoflitration.adsorption, sieving and the challenge of sepsis therapy design. Crit Care 6: 394–396
Sykora R, Chvojka J, Krouzecky A, et al (2009) High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics? Intensive Care Med 35: 371–380
Cruz DN, Antonelli M, Fumagalli R et al (2009) Early use of polymyxin b hemoperfusion in abdominal septic shock: the EUPHAS Randomized Controlled Trial. JAMA 301: 2445–2452
Honore PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: High-volume hemofiltration — A global view. Contrib Nephrol 156: 371–386
Yekebas EF, Eisenberger CF, Ohnnesorge H, et al (2001) Attenuation of sepsis-immunoparalysis with continuous veno venous haemofiltration in experimental porcine pancreatitis. Crit Care Med 29: 1423–1430
Bone RC (1996) Sir Isaac Newton. Sepsis, SIRS and CARS. Crit Care Med 24: 1125–1128
Kellum JA, Song M, Venkataraman R (2004) Hemoadsorption removes tumor necrosis factor, interleukin-o, and interleukin-IO, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 32: 801–805
Li CM, Chen JH, Zhang P, et al (2007) Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 35: 911–919
Matson J R, Zydney AR, Honore PM (2004) Blood filtration: New opportunities and the implications on system biology. Crit Care Resuc 6: 209–218
Ioannes-Boyau O, Honoré PM, Boer W, Collin V (2009) Are the synergistic effects of highvolume haemofiltration and enhanced adsorption the missing key in sepsis modulation? Nephrol Dial Transplant 24: 354–357
Devarajan P (2005) Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 17: 193–199
Rana A, Sathyanarayana P, Lieberthal W (2001) Role of apoptosis of renal tubular cells in acute renal failure:therapeutic implications. Apoptosis 6: 83–102
Boneggio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11: 301–308
Homsi E, Janino P, de Faria JB (2006) Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int 69: 1385–1392
Guo R, Wang Y, Minto AW, Quigg RJ, Cunningham PN (2004) Acute renal failure in endotoxemia is dependant on caspase activation. J Am Soc Nephrol 15: 3093–3102
Mariano F, Cantaluppi V, Stella M, et al (2008) Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 12:R42
Honore PM, Joannes-Boyau O, Boer W, Collin V (2009) High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif 28: 1–11
Palevsky PM, Zhang JH, O'Connor TZ, et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20
Ronco C, Honore PM (2008), Renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 1959–1962
Ronco C, Cruz D, Oudemans-van-Straaten HM, et al (2008) Dialysis dose in acute kidney injury: no time for therapeutic nihilism-a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care 12: 308
Bell M, SWING, Granath F, Schon S, Ekbom A, Martling CR (2007) Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 33: 773–780
Ridel C, Balde MC, Rondeau E, Vinsonneau C (2009) Dose of dialysis in intensive care unit. Reanimation 18: 385–396
Bellomo R, Cass A, Cole L, et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361: 1627–1628
Ioannes-Boyau O, Honore PM Hemofiltration Study: IVOIRE Study. Available at: http://www.clinicaltrials.gov/ct2/show/NCT00241228 Accessed Dec 2009
Ronco C, Bellomo R, Homel P, et al (2000) Effects of different doses in continuous venovenous haemofiltration. Lancet 356: 26–30
Vesconi S, Cruz DN, Fumagalli R, et al (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13: R57
Schiffl H, Lang SM, Fisher R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305–310
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science + Business Media Inc.
About this paper
Cite this paper
Honoré, P.M., Joannes-Boyau, O., Rose, T. (2010). Hemofiltration and Hybrid Therapies in 2010. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5562-3_34
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5562-3_34
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5561-6
Online ISBN: 978-1-4419-5562-3
eBook Packages: MedicineMedicine (R0)